Back to search

Article

The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir

2024-12-07

Abstract excerpt

Lenacapavir (LEN) is a highly potent, long-acting antiretroviral medication for treating people infected with muti-drug-resistant HIV-1 phenotypes. The inhibitor targets multifaceted functions of the viral capsid protein (CA) during HIV-1 replication. Previous studies have mainly focused on elucidating LEN’s mode of action during viral ingress. Additionally, the inhibitor has been shown to interfere with mature ca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
64acb508-6fa4-5f79-af32-f8e5d0a0284c
DOI
10.1101/2024.12.06.627250
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavirDOI 10.1101/2024.12.06.627250
Select a neighboring publication to make it the new centre.